Predictors of attendance in different age groups | 30 years (n = 379) | 40 years (n = 563) | 50 years (n = 218) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | n (%) attending screening | Unadjusted | Adjusted | n (%) attending screening | Unadjusted | Adjusted | n (%) attending screening | Unadjusted | Adjusted |
Mode of transmission, | |||||||||
Heterosexual contact | 197 (70.1) | 1.00‡ | 1.00‡ | 315 (78.6) | 1.00†| 1.00‡ | 132 (89.2) | 1.00‡ | 1.00‡ |
Intravenous drug use | 15 (60.0) | 0.64 (0.28-1.48) | 0.53 (0.21-1.35) | 36 (63.2) | 0.47 (0.26-0.84) | 0.70 (0.35-1.38) | 23 (82.1) | 0.56 (0.19-1.67) | 0.74 (0.22-2.46) |
Other | 4 (57.1) | 0.57 (0.13-2.60) | 0.42 (0.09-2.02) | 8 (66.7) | 0.55 (0.16-1.86) | 0.37 (0.11-1.32) | 3 (100) | -2 | -2 |
(missing) | (66) | Â | Â | (93) | Â | Â | (0) | Â | Â |
Race, | |||||||||
White | 76 (71.0) | 1.00‡ | 1.00‡ | 154 (73.7) | 1.00‡ | 1.00‡ | 89 (84.8) | 1.00‡ | 1.00‡ |
Asian | 36 (62.1) | 0.67 (0.34-1.31) | 0.45 (0.21-0.98) | 42 (80.8) | 1.50 (0.71-3.19) | 1.14 (0.51-2.60) | 12 (92.3) | 2.16 (0.26-17.76) | 1.66 (0.19-14.77) |
Black | 106 (68.8) | 0.90 (0.53-1.54) | 0.72 (0.38-1.34) | 170 (79.8) | 1.41 (0.90-2.23) | 1.29 (0.77-2.18) | 56 (93.3) | 2.52 (0.80-7.91) | 1.81 (0.52-6.26) |
Other | 6 (85.7) | 2.45 (0.28-21.17) | 1.98 (0.22-17.68) | 11 (68.8) | 0.79 (0.26-2.36) | 1.14 (0.32-4.11) | 6 (100) | -1 | -2 |
(missing) | (53) | Â | Â | (73) | Â | Â | (34) | Â | Â |
Calendar period | |||||||||
01.01.2002 – 31.12.20023 | 65 (51.2) | 1.00†| 1.00†| 48 (46.6) | 1.00†| 1.00†| 8 (72.7) | 1.00‡ | 1.00‡ |
01.01.2003 – 31.12.2010 | 163 (64.7) | 1.75 (1.13-2.69) | 1.77 (1.04-3.02) | 329 (71.5) | 2.88 (1.86-4.45) | 3.45 (2.05-5.78) | 156 (75.4) | 1.15 (0.29-4.49) | 1.04 (0.12-9.33) |
Time-updated HIV RNA (copies/mL) | |||||||||
> 500 | 86 (52.8) | 1.00†| 1.00‡ | 90 (54.2) | 1.00†| 1.00†| 29 (60.4) | 1.00†| 1.00‡ |
< 500 | 137 (66.8) | 1.80 (1.18-2.75) | 1.37 (0.83-2.28) | 279 (73.0) | 2.29 (1.57-3.34) | 1.76 (1.08-2.88) | 130 (79.8) | 2.58 (1.29-5.16) | 2.43 (0.88-6.71) |
(missing) | (11) | Â | Â | (15) | Â | Â | (7) | Â | Â |
Time-updated CD4 count (cells/μL) | |||||||||
< 200 | 33 (56.9) | 1.00‡ | 1.00‡ | 40 (56.3) | 1.00†| 1.00‡ | 14 (58.3) | 1.00‡ | 1.00‡ |
200–350 | 42 (52.5) | 0.84 (0.42-1.65) | 0.49 (0.21-1.13) | 61 (58.7) | 1.10 (0.60-2.02) | 0.67 (0.30-1.51) | 24 (70.6) | 1.71 (0.57-5.13) | 1.54 (0.36-6.53) |
> 350 | 147 (63.9) | 1.34 (0.75-2.41) | 0.76 (0.36-1.61) | 269 (71.9) | 2.00 (1.18-3.34) | 1.07 (0.52-2.19) | 121 (79.1) | 2.70 (1.10-6.64) | 4.33 (1.24-15.10) |
(missing) | (11) | Â | Â | (14) | Â | Â | (7) | Â | Â |